Phio Pharmaceuticals (PHIO) Institutional Ownership $2.45 +0.02 (+0.82%) Closing price 04:00 PM EasternExtended Trading$2.48 +0.03 (+1.22%) As of 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Phio Pharmaceuticals (NASDAQ:PHIO)CurrentInstitutional OwnershipPercentage57.31%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$73.64KNumber ofInstitutional Sellers(last 12 months)0 Get PHIO Insider Trade Alerts Want to know when executives and insiders are buying or selling Phio Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PHIO Institutional Buying and Selling by Quarter Phio Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/11/2025Virtu Financial LLC40,910$74K0.0%N/A0.594% 8/14/2023Anson Funds Management LP22,571$65K0.0%N/A1.505% 8/10/2023Cetera Investment Advisers10,666$31K0.0%N/A0.711% 8/2/2023Bank of Montreal Can10,000$38K0.0%N/A0.667% 8/11/2022Cetera Investment Advisers75,000$53K0.0%-16.7%0.549% 11/16/2021Cetera Investment Advisers30,000$61K0.0%N/A0.222% 11/9/2021BlackRock Inc.35,592$72K0.0%-17.8%0.263% 9/17/2021Virtu Financial LLC27,110$61K0.0%+74.7%0.200% 8/13/2021Vanguard Group Inc.276,561$625K0.0%+125.4%2.043% 8/12/2021Dimensional Fund Advisors LP23,960$54K0.0%-31.2%0.177% 5/19/2021Virtu Financial LLC15,522$42K0.0%N/A0.115% 5/14/2021Dimensional Fund Advisors LP34,808$93K0.0%+38.3%0.257% 5/12/2021Geode Capital Management LLC87,501$234K0.0%+330.6%0.647% (Data available from 1/1/2016 forward) PHIO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PHIO shares? During the previous two years, the following institutional investors and hedge funds held shares of Phio Pharmaceuticals shares: Virtu Financial LLC ($74K), Anson Funds Management LP ($65K), and Bank of Montreal Can ($38K), Cetera Investment Advisers ($31K).Learn more on Phio Pharmaceuticals' institutional investors. What percentage of Phio Pharmaceuticals' stock is owned by institutional investors? 57.31% of Phio Pharmaceuticals' stock is owned by institutional investors. Learn more on PHIO's institutional investor holdings. Which institutional investors have been buying Phio Pharmaceuticals' stock? The following institutional investors have purchased Phio Pharmaceuticals' stock in the last 24 months: Virtu Financial LLC ($40.91K), Anson Funds Management LP ($22.57K), Cetera Investment Advisers ($10.67K), and Bank of Montreal Can ($10K). How much institutional buying is happening at Phio Pharmaceuticals? Institutional investors have bought a total of 40,910 shares in the last 24 months. This purchase volume represents approximately $73.64K in transactions. Related Companies ANVS Institutional Ownership MDCX Institutional Ownership APLT Institutional Ownership PLUR Institutional Ownership PRLD Institutional Ownership MURA Institutional Ownership ATNM Institutional Ownership SCLX Institutional Ownership GRCE Institutional Ownership XCUR Institutional Ownership This page (NASDAQ:PHIO) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredFREE BUY ALERT: These 3 tiny AI stocks could surgeWe're living in unprecedented times. Most people think it's too late to get into AI right now … That the...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Phio Pharmaceuticals Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Phio Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PHIO Stock Alerts